Catheter Ablation for Atrial Fibrillation with Heart Failure
Jan 31, 2018 · In the CASTLE-AF trial, in contrast to previous trials, we evaluated the hard primary end point of death or hospitalization for heart failure.
Searching…
Jan 31, 2018 · In the CASTLE-AF trial, in contrast to previous trials, we evaluated the hard primary end point of death or hospitalization for heart failure.
About us CASTLE Lab at HKUST CASTLE (C ode A nalysi S, T esting and LE arning) Lab is a part of Software Engineering Group in HKUST. The lab is headed by Prof. Shing-Chi Cheung. We are interested in research topices r...
Aug 30, 2024 · Herein, we present the 2-year follow-up data from the CASTLE-HTx trial. CASTLE-HTx randomized 194 patients with end-stage HF and symptomatic AF to receive catheter ablation and guideline-directed medica...
The primary objective of the CASTLE‐HTx study is to evaluate the effects of catheter‐based ablation of AF in patients eligible for HTx on the composite endpoint of ‘all‐cause mortality, transplantation, or implantatio...
Sep 5, 2023 · 2023年8月26日,欧洲心脏病学会(ESC)年会在荷兰隆重召开期间,德国莱比锡心脏中心Philipp Sommer教授和新南威尔士州心脏与糖尿病中心Christian Sohns教授所发表的CASTLE-HTx试验结果,为导管消融治疗心房颤动终末期心衰患者提供了有力循证依据。
Aug 30, 2023 · CASTLE-HTx研究显示,房颤导管消融可以降低终末期心衰患者具有心脏移植指征的复合终点,包括总死亡率、心衰恶化需要紧急心脏移植或紧急植入左心室辅助装置为心脏移植过渡的发生率。
Sep 11, 2023 · In the CASTLE HTx trial, patients with symptomatic atrial fibrillation and end-stage heart failure who underwent catheter ablation and received medical therapy had improved outcomes compared with...
CASTLE-AF is the first large, randomized study providing clinical evidence that ablation of atrial fibrillation improves hard outcome parameters in heart failure patients
May 22, 2024 · CASTLE-HTx研究深入探讨了消融术在晚期心力衰竭患者中的应用,并提供了一个风险评分系统(CASTLE-HTx风险评分),帮助医生识别最有可能从消融术中获益的患者群体。
Aug 27, 2023 · We conducted the randomized CASTLE-HTx (Catheter Ablation for Atrial Fibrillation in Patients with End-Stage Heart Failure and Eligibility for Heart Transplantation) trial to assess the safety...